Edesa Biotech Inc (EDSA)
2.15
-0.02
(-0.92%)
USD |
NASDAQ |
Nov 25, 16:00
2.55
+0.40
(+18.60%)
After-Hours: 20:00
Edesa Biotech Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2020 | 0.3288M |
| June 30, 2020 | 0.7387M |
| March 31, 2020 | 0.6292M |
| December 31, 2019 | 0.6364M |
| September 30, 2019 | 0.5817M |
| June 30, 2019 | 0.2255M |
| March 31, 2019 | 0.2981M |
| December 31, 2018 | 0.2444M |
| September 30, 2018 | 0.2118M |
| June 30, 2018 | 0.1605M |
| March 31, 2018 | 0.108M |
| December 31, 2017 | 0.1069M |
| September 30, 2017 | 0.2283M |
| June 30, 2017 | 0.5015M |
| March 31, 2017 | 0.6621M |
| December 31, 2016 | 0.9254M |
| September 30, 2016 | 1.272M |
| June 30, 2016 | 1.196M |
| March 31, 2016 | 1.173M |
| December 31, 2015 | 1.034M |
| Date | Value |
|---|---|
| September 30, 2015 | 0.7587M |
| June 30, 2015 | 0.6773M |
| March 31, 2015 | 0.6222M |
| December 31, 2014 | 0.5256M |
| August 31, 2014 | 0.3721M |
| May 31, 2014 | 0.5479M |
| February 28, 2014 | 0.5185M |
| November 30, 2013 | 0.4889M |
| August 31, 2013 | 0.5455M |
| May 31, 2013 | 0.2997M |
| February 28, 2013 | 0.2697M |
| November 30, 2012 | 0.2664M |
| August 31, 2012 | 0.2861M |
| May 31, 2012 | 0.2771M |
| February 29, 2012 | 0.2755M |
| November 30, 2011 | 0.7627M |
| August 31, 2011 | 0.6972M |
| May 31, 2011 | 1.202M |
| February 28, 2011 | 1.322M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.3288M
Minimum
Sep 2020
0.7387M
Maximum
Jun 2020
0.5833M
Average
0.6328M
Median
Revenue (TTM) Benchmarks
| Aurinia Pharmaceuticals Inc | 220.36M |
| Lexaria Bioscience Corp | 0.411M |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |
| ImmunoPrecise Antibodies Ltd | 17.73M |